Metabolic Bone Disease News and Research

RSS

Risks of developing kidney failure, calcium deficiency from zoledronic acid are extremely rare

The risks of developing kidney failure and a calcium deficiency from the popular osteoporosis drug zoledronic acid are extremely rare, according to researchers at Loyola University Health System. These findings were presented earlier this month at the American Society for Bone and Mineral Research's annual meeting.

31 Oct 2013

New open access Journal of Clinical and Translational Endocrinology from Elsevier

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of a new open access research publication - Journal of Clinical and Translational Endocrinology (JCTE).

12 Sep 2013

UCSF Professor receives Olof Johnell Science Award for achievements in metabolic bone disease

Harry Genant, Professor Emeritus of the University of California San Francisco, has been named the winner of the International Osteoporosis Foundation's (IOF) first Olof Johnell Science Award.

19 Apr 2013

U.S. News & World Report names Hospital for Special Surgery among 2012 America's Best Hospitals

For the third consecutive year, U.S. News & World Report named Hospital for Special Surgery the top hospital in the country for orthopedics in its 2012 "America's Best Hospitals" survey. Once again, the hospital ranked as a leader in rheumatology at number three in the nation. In addition, neurology was ranked at No. 10.

17 Jul 2012

Scientists discover two key epigenetic regulating genes that govern stem cell differentiation

The ability to control whether certain stem cells ultimately become bone cells holds great promise for regenerative medicine and potential therapies aimed at treating metabolic bone diseases. Now, UCLA School of Dentistry professor and leading cancer scientist Dr. Cun-Yu Wang and his research team have made a significant breakthrough in that direction. The scientists have discovered two key epigenetic regulating genes that govern the cell-fate determination of human bone marrow stem cells.

10 Jul 2012

Vitamin D deficiency associated with increase in lung transplant rejection, infections

Vitamin D deficiency is associated with an increase in lung transplant rejection and infections, according to research conducted at Loyola University Health System.

25 Apr 2012

Doctors identify promising new treatment for hypophosphatasia

Doctors at Washington University School of Medicine in St. Louis, working with Shriners Hospital for Children and other institutions, have identified a promising new treatment for a rare and sometimes life-threatening bone disorder that can affect infants and young children.

8 Mar 2012

People with celiac disease are at risk for osteoporosis

People with celiac disease are at risk for osteoporosis, according to physicians at Loyola University Health System (LUHS). A 2009 New England Journal of Medicine study supports this correlation. Researchers believe that people with celiac disease may develop osteoporosis because their body poorly absorbs calcium and vitamin D, which are necessary for bone health.

22 Feb 2012

Loyola to study vitamin D deficiency in people of African descent

Loyola University Chicago Stritch School of Medicine researchers have received a five-year, $2.8 million grant from the National Institutes of Health to study vitamin D deficiency in people of African descent.

1 Dec 2011

BUSM professor receives 2011 ACN Communication Media Award

Michael F. Holick, PhD, MD, director of the General Clinical Research Unit and professor of medicine, physiology and biophysics at Boston University School of Medicine (BUSM) was selected by the American College of Nutrition (ACN) Awards Committee as the 2011 recipient of the ACN Communication Media Award.

23 Nov 2011

U.S. News & World Report ranks HSS as No.1 orthopedic hospital

U.S. News & World Report has once again named Hospital for Special Surgery (HSS) the top hospital in the country for orthopedics in its 2011 "America's Best Hospitals" issue.

19 Jul 2011

Vitamin D insufficiency may increase risk of muscle injuries in NFL football players

Vitamin D deficiency has been known to cause an assortment of health problems, a recent study being presented at the American Orthopaedic Society for Sports Medicine's (AOSSM) Annual Meeting in San Diego today, suggests that lack of the vitamin might also increase the chance of muscle injuries in athletes, specifically NFL football players.

11 Jul 2011

Loyola to launch interdisciplinary Geriatric Fracture Program

Loyola University Hospital is launching an interdisciplinary Geriatric Fracture Program to reduce hospital stays and complications from broken hips and other age-related fractures.

7 Jul 2011

HSS orthopedic surgeon earns recognition for research on metabolic bone disease

Joseph M. Lane, M.D., an orthopedic surgeon nationally recognized for his work in metabolic bone disease, will receive the Lifetime Achievement Award at the hospital's 28th Annual Tribute Dinner on Monday, June 20, for his innovative research on bone disease and the use of bisphosphonates in treating osteoporosis. Brian Williams, anchor of Nightly News on NBC, will serve as toastmaster.

21 Jun 2011

Higher than IOM recommended Vitamin D levels required for optimizing osteoporosis, low BMD therapy

To fully optimize a drug therapy for osteoporosis and low bone mineral density (BMD), patients should maintain vitamin D levels above the limits recently recommended by the Institute of Medicine (IOM), according to a new study by researchers from Hospital for Special Surgery in New York. The study will be presented at the Endocrine Society's Annual Meeting in Boston, June 4-7.

7 Jun 2011

Enobia completes patient enrollment in ENB-0040 Phase II study for HPP

Enobia Pharma Inc., today announced that it has successfully completed enrollment in its Phase II study of ENB-0040, a bone targeted enzyme replacement therapy being investigated in adolescents and adults with hypophosphatasia, a serious, rare metabolic bone disorder.

25 Feb 2011

AACE releases new medical guidelines for diagnosis and treatment of postmenopausal osteoporosis

The American Association of Clinical Endocrinologists (AACE) has released new medical guidelines for the diagnosis and treatment of postmenopausal osteoporosis. Loyola physician Pauline Camacho, MD, was part of a committee that developed the guidelines to manage this major public health issue.

20 Jan 2011

Doctors recommend drug holidays from bisphosphonates to enhance bone health

Taking time off from certain osteoporosis drugs may be beneficial to bone health, according to a study conducted at Loyola University Health System. Researchers found that bone density remained stable for three years in patients who took a drug holiday from bisphosphonates, a popular class of osteoporosis drugs that can cause fractures in the thigh bones and tissue decay in the jaw bone.

19 Nov 2010

Endocrine Society unveils new guideline on endocrine and nutritional management of post-bariatric surgery patients

The Endocrine Society released a new clinical practice guideline for the nutritional and endocrine management of adults after bariatric surgery, including those with diabetes mellitus. The guideline features a series of evidence-based clinical recommendations developed by an expert task force. The guideline is published in the November 2010 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.

4 Nov 2010

Study indicates vitamin D deficiency may increase lung transplant rejection

Vitamin D deficiency is associated with a significant increase in lung transplant rejection, according to research conducted at Loyola University Health System (LUHS). These data were presented Monday at The American Society for Bone and Mineral Research 2010 annual meeting in Toronto, Ontario.

19 Oct 2010